Your browser doesn't support javascript.
loading
Reclassification of a likely pathogenic Dutch founder variant in KCNH2; implications of reduced penetrance.
Copier, Jaël S; Bootsma, Marianne; Ng, Chai A; Wilde, Arthur A M; Bertels, Robin A; Bikker, Hennie; Christiaans, Imke; van der Crabben, Saskia N; Hol, Janna A; Koopmann, Tamara T; Knijnenburg, Jeroen; Lommerse, Aafke A J; van der Smagt, Jasper J; Bezzina, Connie R; Vandenberg, Jamie I; Verkerk, Arie O; Barge-Schaapveld, Daniela Q C M; Lodder, Elisabeth M.
Afiliação
  • Copier JS; Experimental Cardiology, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
  • Bootsma M; Amsterdam Cardiovascular Sciences, Heart Failure & Arrhythmias, Amsterdam, The Netherlands.
  • Ng CA; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart: ERN GUARD-Heart'.
  • Wilde AAM; Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 Leiden, The Netherlands.
  • Bertels RA; Mark Cowley Lidwill Research Program in Cardiac Electrophysiology, Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia.
  • Bikker H; School of Clinical Medicine, UNSW Sydney, Darlinghurst, New South Wales, Australia.
  • Christiaans I; Experimental Cardiology, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
  • van der Crabben SN; Amsterdam Cardiovascular Sciences, Heart Failure & Arrhythmias, Amsterdam, The Netherlands.
  • Hol JA; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart: ERN GUARD-Heart'.
  • Koopmann TT; Department of Paediatric Cardiology, Leiden University Medical Center, Willem-Alexander Children's Hospital, Albinusdreef 2, 2333 Leiden, Netherlands.
  • Knijnenburg J; European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart: ERN GUARD-Heart'.
  • Lommerse AAJ; Human Genetics, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
  • van der Smagt JJ; Department of Clinical Genetics, University Medical Centre Groningen, 9713GZ Groningen, The Netherlands.
  • Bezzina CR; Human Genetics, Amsterdam UMC location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
  • Vandenberg JI; Erasmus MC, Clinical Genetics, Doctor Molewaterplein 40, 3015 Rotterdam, The Netherlands.
  • Verkerk AO; Clinical Genetics, Leiden University Medical Center, Albinusdreef 2, 2333 Leiden, The Netherlands.
  • Barge-Schaapveld DQCM; Clinical Genetics, Leiden University Medical Center, Albinusdreef 2, 2333 Leiden, The Netherlands.
  • Lodder EM; Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 Leiden, The Netherlands.
Hum Mol Genet ; 32(7): 1072-1082, 2023 03 20.
Article em En | MEDLINE | ID: mdl-36269083
BACKGROUND: Variants in KCNH2, encoding the human ether a-go-go (hERG) channel that is responsible for the rapid component of the cardiac delayed rectifier K+ current (IKr), are causal to long QT syndrome type 2 (LQTS2). We identified eight index patients with a new variant of unknown significance (VUS), KCNH2:c.2717C > T:p.(Ser906Leu). We aimed to elucidate the biophysiological effect of this variant, to enable reclassification and consequent clinical decision-making. METHODS: A genotype-phenotype overview of the patients and relatives was created. The biophysiological effects were assessed independently by manual-, and automated calibrated patch clamp. HEK293a cells expressing (i) wild-type (WT) KCNH2, (ii) KCNH2-p.S906L alone (homozygous, Hm) or (iii) KCNH2-p.S906L in combination with WT (1:1) (heterozygous, Hz) were used for manual patching. Automated patch clamp measured the variants function against known benign and pathogenic variants, using Flp-In T-rex HEK293 KCNH2-variant cell lines. RESULTS: Incomplete penetrance of LQTS2 in KCNH2:p.(Ser906Leu) carriers was observed. In addition, some patients were heterozygous for other VUSs in CACNA1C, PKP2, RYR2 or AKAP9. The phenotype of carriers of KCNH2:p.(Ser906Leu) ranged from asymptomatic to life-threatening arrhythmic events. Manual patch clamp showed a reduced current density by 69.8 and 60.4% in KCNH2-p.S906L-Hm and KCNH2-p.S906L-Hz, respectively. The time constant of activation was significantly increased with 80.1% in KCNH2-p.S906L-Hm compared with KCNH2-WT. Assessment of KCNH2-p.S906L-Hz by calibrated automatic patch clamp assay showed a reduction in current density by 35.6%. CONCLUSION: The reduced current density in the KCNH2-p.S906L-Hz indicates a moderate loss-of-function. Combined with the reduced penetrance and variable phenotype, we conclude that KCNH2:p.(Ser906Leu) is a low penetrant likely pathogenic variant for LQTS2.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Síndrome do QT Longo Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Hum Mol Genet Assunto da revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Síndrome do QT Longo Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Revista: Hum Mol Genet Assunto da revista: BIOLOGIA MOLECULAR / GENETICA MEDICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda